Description
Glipden-MV1 contains Glimepiride 1mg, Metformin Hydrochloride (SR) 500mg and Voglibose 0.2mg, a triple-combination antidiabetic therapy indicated for the management of Type 2 diabetes mellitus, as prescribed by a healthcare professional.
Composition:
Glimepiride 1mg + Metformin Hydrochloride (SR) 500mg + Voglibose 0.2mg
Pack Size:
10X10 Tablets
Packing:
Blister
Therapeutic Segment:
Diabetology | Cardio-Diabetic Care
Key Benefits:
• Helps improve glycaemic control in Type 2 diabetes mellitus
• Supports fasting and postprandial blood glucose management
• Triple-combination therapy with complementary mechanisms of action
• To be used only under medical supervision
• Convenient oral tablet formulation
Packaging:
10X10 Blister Pack
Reviews
There are no reviews yet.